Search results for : fgfr1 - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Search Results for: fgfr1

Drugs (8)

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
AZD4547	AZ6	FGFR1, FGFR2, FGFR3	RTK signaling		GDSC1	873	SANGER
AZD4547	1035270-39-3	FGFR1, FGFR2, FGFR3	RTK signaling	51039095	GDSC2	959	SANGER
FGFR_3831	SN1037992934	FGFR1, FGFR2, FGFR3, FGFR4	RTK signaling		GDSC1	917	SANGER
Foretinib	GSK1363089, XL-880, EXEL-2880, GSK089	MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR	RTK signaling	42642645	GDSC1	909	MGH
Foretinib	GSK1363089, XL-880, EXEL-2880, GSK089	MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR	RTK signaling	42642645	GDSC2	953	SANGER
PD173074	PD-173074, PD 173074	FGFR1, FGFR2, FGFR3	RTK signaling	1401	GDSC1	932	SANGER
PD173074	PD-173074, PD 173074	FGFR1, FGFR2, FGFR3	RTK signaling	1401	GDSC2	967	SANGER
Ponatinib	AP24534, AP-24534, KIN001-192, Iclusig	ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3	Other, kinases	24826799	GDSC1	877	MGH

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).